OCGN Q3 2019 Earnings — Ocugen, Inc. Revenue & Financial Results | Market Cap Arena

OCGNOcugen, Inc.

$710M

Q3 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$3M

Net Income

-$23M

EPS (Diluted)

$-3.55

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

$3M

Free Cash Flow

$3M

Stock-Based Comp.

$576,014

Balance Sheet

Total Assets

$24M

Total Liabilities

$37M

Stockholders' Equity

-$13M

Cash & Equivalents

$15M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$3M	-$7M	+61.2%
Net Income	-$23M	$11M	-313.8%